26-A-15097-ACC IMPACT OF PCSK9 INHIBITORS (ALIROCUMAB AND EVOLOCUMAB) ON PATIENTS WITH CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) ON MAXIMAL STATIN THERAPY AND ADVANCED CHRONIC KIDNEY DISEASE (CKD): A PROPENSITY-MATCHED ANALYSIS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Lipoproteins and Cardiovascular Health
Chronic Kidney Disease and Diabetes
Antiplatelet Therapy and Cardiovascular Diseases
Publication details
- Journal / source
- Journal of the American College of Cardiology
- Volume
- 87
- Issue
- 13
- Pages
- A275–A275
- Publication date
- 27 March 2026
- Language
- EN